✦ LIBER ✦

519 Preclinical evaluation of the second generation vascular disrupting agent OXI 4503

✍ Scribed by W. Shi; H.W. Salmon; A.M. Rojiani; D.W. Siemann

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preclinical evaluation of the antitumour

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 142 KB

Evaluations of vascular disrupting agent

✍ Howard W. Salmon; Christopher Mladinich; Dietmar W. Siemann 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 793 KB

Synthesis and biological evaluation of i

✍ MacDonough, Matthew T.; Strecker, Tracy E.; Hamel, Ernest; Hall, John J.; Chapli 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 575 KB